pageInfo({
    time : "1261009669127"
  
	    , page : null
	  
	    , url : null
	  
	    , instrument : null
	  
	    , article : {
	        storyId : "USN3044597720080531"
	        , headline : "Avastin plus chemo better without Erbitux"
	        , keywords : "[Philippines, Asia, Pharmaceuticals - diversified, Online Report text item, Chemicals, Biotechnology, Switzerland, Western Europe, Europe, Pharmaceuticals (sub-industry), Health and medicine, United States of America, Canada]"
	        , tickers : "[AMGN.O, MRCG.DE, mx;AMGN, mx;BMY, ROG.VX, us;AMGN, us;BMY, us;DNA, us;IMCL, us;MERP, us;MRK, us;RHHQ, us;RHHV, IMCL.O, DNA.N, BMY.N, ch;AMGN, ch;MRK, ch;RO, de;BRM, de;BRMF, de;BRMS, de;BRMX, de;MRK, de;MRKX, de;RHO, de;RHOF, xt;RO]"
	    }
	    , channel : {
	        id : "14"
	        , name : "healthNews"
	        , title : "Health News"
	    }})